1000-1001 / 1173
T
1/2
for late-responding human tissues
Endpoint
T
1/2
(h)
2.5%-tile (h)
97.5%-tile (h)
Laryngeal oedema
4.9
3.7
6.1
Skin telangiectasia
3.8
2.9
4.5
Subcutaneous
changes
4.4
4.0
4.8
Bentzen et al.
Radiother & Oncol
53: 219 (1999)